Inactive Instrument

News SPINEGUAR0 Euronext Paris

Equities

FR0011464452

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

07-08	SpineGuard: capital increase completed	CF
04-17	SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SpineGuard: capital increase completed	07-08	CF
SpineGuard Reports on Its Annual Shareholders’ Meeting of June 26, 2024	06-26	BU
SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales	04-17	BU
SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023	04-17	CI
SpineGuard Reaches a Significant Regulatory Milestone to Strenghthen its PediGuard® Offering in China	03-05	BU
SpineGuard SA announced that it expects to receive ?1.998 million in funding	11-14	CI
12 October 2023 – 11H00 CET: SpineGuard note by BioStrategic Research (in english)	23-10-12	PU
Spineguard Sa Reports Unaudited Revenue Result for the Third Quarter and Year to Date Nine Months for the Year 2023	23-10-11	CI
13 September 2023 – 18H00 CET: SpineGuard note by BioStrategic Research (in english)	23-09-13	PU
SpineGuard SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-12	CI
SpineGuard Wins Patent for Dynamic Surgical Guidance Technology in Brazil	23-09-06	MT
SpineGuard Strengthens its Intellectual Property with a New Patent Granted in Brazil	23-09-05	CI
12 July 2023 – 18H00 CET: SpineGuard note by BioStrategic Research (in english)	23-07-13	PU
XinRong Medical places a large purchase order of PediGuardÂ® devices and invests in SpineGuard to boost DSGÂ® technologyâ€™s deployment in China	23-07-13	CI
SpineGuard: bond financing put in place	23-06-01	CF
SpineGuard SA Announces CFO Changes	23-05-31	CI
SpineGuard SA announced that it expects to receive €7.5 million in funding from Nice & Green SA	23-05-30	CI
SpineGuard's Shares Soar 24% on Expansion of Partnership with China's XinRong Medical Group	23-05-16	MT
SpineGuard SA announced that it has received â‚¬0.5 million in funding from SuZhou Xinrong Best Medical Instrument Co., Ltd	23-05-15	CI
17 April 2023 – 18H00 CET: SpineGuard note by BioStrategic Research (in english)	23-04-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SPINEGUAR0 Euronext Paris

Equities

FR0011464452

Summary

Filters